NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,000 | -57.7% | 13,080 | +8.8% | 0.00% | – |
| Q2 2023 | $499,000 | +20.8% | 12,021 | +74.9% | 0.00% | – |
| Q1 2023 | $413,000 | -70.9% | 6,872 | -64.5% | 0.00% | – |
| Q4 2022 | $1,420,000 | -6.9% | 19,346 | -3.7% | 0.00% | – |
| Q3 2022 | $1,525,000 | +17.9% | 20,081 | +7.9% | 0.00% | – |
| Q2 2022 | $1,294,000 | -16.5% | 18,608 | -0.5% | 0.00% | – |
| Q1 2022 | $1,550,000 | -90.3% | 18,697 | -91.2% | 0.00% | -100.0% |
| Q4 2021 | $15,977,000 | -37.7% | 212,818 | -3.5% | 0.00% | -57.1% |
| Q3 2021 | $25,629,000 | -75.5% | 220,608 | -53.2% | 0.01% | -74.1% |
| Q2 2021 | $104,640,000 | +22.2% | 471,734 | -27.2% | 0.03% | +8.0% |
| Q1 2021 | $85,652,000 | +31.8% | 647,998 | +72.5% | 0.02% | +31.6% |
| Q4 2020 | $64,991,000 | +168.6% | 375,573 | +72.8% | 0.02% | +111.1% |
| Q3 2020 | $24,199,000 | +1865.8% | 217,403 | +948.1% | 0.01% | – |
| Q2 2020 | $1,231,000 | -46.1% | 20,743 | -38.8% | 0.00% | -100.0% |
| Q1 2020 | $2,283,000 | -76.4% | 33,901 | -70.4% | 0.00% | -66.7% |
| Q4 2019 | $9,654,000 | -25.6% | 114,560 | -34.0% | 0.00% | -40.0% |
| Q3 2019 | $12,977,000 | +96.8% | 173,538 | +66.4% | 0.01% | +150.0% |
| Q2 2019 | $6,595,000 | -43.6% | 104,295 | -57.0% | 0.00% | -60.0% |
| Q1 2019 | $11,697,000 | +57.4% | 242,826 | +9.4% | 0.01% | +66.7% |
| Q4 2018 | $7,431,000 | +655.2% | 221,993 | +1083.3% | 0.00% | – |
| Q3 2018 | $984,000 | -77.2% | 18,761 | -86.4% | 0.00% | -100.0% |
| Q2 2018 | $4,324,000 | +72.3% | 138,142 | +20.0% | 0.00% | +100.0% |
| Q1 2018 | $2,509,000 | +15.0% | 115,102 | +6.5% | 0.00% | 0.0% |
| Q4 2017 | $2,182,000 | +1374.3% | 108,035 | +1351.3% | 0.00% | – |
| Q3 2017 | $148,000 | +2366.7% | 7,444 | +2142.2% | 0.00% | – |
| Q2 2017 | $6,000 | -64.7% | 332 | -84.4% | 0.00% | – |
| Q1 2017 | $17,000 | -37.0% | 2,124 | -38.2% | 0.00% | – |
| Q4 2016 | $27,000 | +8.0% | 3,435 | +57.6% | 0.00% | – |
| Q2 2016 | $25,000 | -97.8% | 2,180 | -97.3% | 0.00% | – |
| Q1 2016 | $1,149,000 | – | 79,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |